Skip to content
DataLookout
Menu

NCT07903051

Lemborexant on Perioperative Sleep Quality in Patients With Brain Tumor Undergoing Surgery

StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Total Sleep Time (TST) on the Night Before Surgery
Timeframe: Night before surgery

Secondary (11)

Subjective sleep quality
Objective sleep quality
Time to Extubation
Time to Awakening
Perioperative Anxiety Visual Analog Scale (VAS-A) Score
Show 6 moreShow less
Postoperative Hospital Anxiety and Depression Scale (HADS) Score
Postoperative pain measured by Pain Numeric Rating Scale (NRS) score
Postoperative Quality of Recovery-15 (QoR-15)
Incidence of Postoperative Delirium
Pittsburgh Sleep Quality Index (PSQI) Score at 1 Month After Surgery
Karnofsky Performance Status (KPS) Score at 1 Month After Surgery

Arms and interventions

Lemborexant 5 mgExperimental

Participants will receive a single oral dose of lemborexant 5 mg tablet on the night before brain tumor surgery.

PlaceboPlacebo comparator

Participants will receive a single oral dose of matching placebo tablet on the night before brain tumor surgery.

Drugs: Lemborexant 5 mg, placebo